Septum primum development

pathway activity — cross-omics
GO:0003284Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Septum primum development pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CDKN3, MYBL2, and E2F1, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Septum primum development activity versus CDKN3 in GBM (Pearson r = 0.28).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMCDKN3 →+1.029+0.851<.001.00136
BRCAMYBL2 →+1.410+0.323<.001.00236
GBME2F1 →+1.033+1.084<.001<.00136
BRCANCAPD2 →+0.675+0.277.001.00636
LSCCRAD51AP1 →+0.957+0.814<.001.00136
BRCACDCA3 →+1.030+0.350<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0003284 vs CDKN3 — GBM

Per-sample scatter of Septum primum development activity vs CDKN3 in GBM.

Explore this scatter interactively →

Exploration